This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldmann, O.
Right arrow Articles by Medina, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldmann, O.
Right arrow Articles by Medina, E.

 Previous Article  |  Next Article 

Infection and Immunity, May 2004, p. 2956-2963, Vol. 72, No. 5
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.5.2956-2963.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Role of Macrophages in Host Resistance to Group A Streptococci

Oliver Goldmann, Manfred Rohde, Gursharan Singh Chhatwal, and Eva Medina*

Department of Microbial Pathogenesis and Vaccine Research, GBF-German Research Centre for Biotechnology, Braunschweig, Germany

Received 5 December 2003/ Returned for modification 30 December 2003/ Accepted 28 January 2004

Macrophages provide the first line of defense against invading pathogens. The aim of this study was to determine the role of macrophages during infection with group A streptococci (Streptococcus pyogenes) in mice. Here, we report that resident macrophages can efficiently take up and kill S. pyogenes during in vivo infection, as demonstrated by immunofluorescence and electron microscopy, as well as colony counts. To evaluate the contribution of macrophages to the resolution of experimental infection with S. pyogenes, we compared the susceptibility of BALB/c mice rendered macrophage deficient by treatment with carrageenan with that of intact mice. The results show that depletion of macrophages enhanced the susceptibility of BALB/c mice to S. pyogenes infection, as evidenced by 100% mortality of macrophage-depleted mice compared to 90% survival of nondepleted control animals. The in vivo depletion of macrophages strongly enhanced bacterial loads in the blood and systemic organs. Resistance to S. pyogenes can be restored in macrophage-depleted mice by adoptive transfer of purified macrophages. The in vivo blocking of the macrophage phagocytic function by treatment with gadolinium III chloride also resulted in enhanced susceptibility to S. pyogenes. Interestingly, depletion of macrophages prior to or during the first 24 h of infection decreased survival dramatically; in contrast, no mortality was observed in infected nondepleted animals or mice depleted after 48 h of infection. These results emphasize the important contribution of macrophages to the early control of S. pyogenes infection.


* Corresponding author. Mailing address: Department of Microbial Pathogenesis and Vaccine Research, GBF-German Research Center for Biotechnology, Mascheroder Weg 1, 38124 Braunschweig, Germany. Phone: 0531/6181466. Fax: 0531/6181708. E-mail: eme{at}gbf.de.

Editor: D. L. Burns


Infection and Immunity, May 2004, p. 2956-2963, Vol. 72, No. 5
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.5.2956-2963.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Timmer, A. M., Timmer, J. C., Pence, M. A., Hsu, L.-C., Ghochani, M., Frey, T. G., Karin, M., Salvesen, G. S., Nizet, V. (2009). Streptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis. J. Biol. Chem. 284: 862-871 [Abstract] [Full Text]  
  • Gratz, N., Siller, M., Schaljo, B., Pirzada, Z. A., Gattermeier, I., Vojtek, I., Kirschning, C. J., Wagner, H., Akira, S., Charpentier, E., Kovarik, P. (2008). Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9. J. Biol. Chem. 283: 19879-19887 [Abstract] [Full Text]  
  • Cho, K. H., Caparon, M. G. (2008). tRNA Modification by GidA/MnmE Is Necessary for Streptococcus pyogenes Virulence: a New Strategy To Make Live Attenuated Strains. Infect. Immun. 76: 3176-3186 [Abstract] [Full Text]  
  • Loof, T. G., Goldmann, O., Medina, E. (2008). Immune Recognition of Streptococcus pyogenes by Dendritic Cells. Infect. Immun. 76: 2785-2792 [Abstract] [Full Text]  
  • Maletzki, C, Linnebacher, M, Kreikemeyer, B, Emmrich, J (2008). Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model. Gut 57: 483-491 [Abstract] [Full Text]  
  • von Kockritz-Blickwede, M., Goldmann, O., Thulin, P., Heinemann, K., Norrby-Teglund, A., Rohde, M., Medina, E. (2008). Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 111: 3070-3080 [Abstract] [Full Text]  
  • Phelps, H. A., Neely, M. N. (2007). SalY of the Streptococcus pyogenes Lantibiotic Locus Is Required for Full Virulence and Intracellular Survival in Macrophages. Infect. Immun. 75: 4541-4551 [Abstract] [Full Text]  
  • Nomi, H., Tashiro-Yamaji, J., Yamamoto, Y., Miura-Takeda, S., Miyoshi-Higashino, M., Takahashi, T., Azuma, H., Ueda, H., Katsuoka, Y., Kubota, T., Yoshida, R. (2007). Acute Rejection of Allografted CTL-Susceptible Leukemia Cells from Perforin/Fas Ligand Double-Deficient Mice. J. Immunol. 179: 2180-2186 [Abstract] [Full Text]  
  • Goldmann, O., von Kockritz-Blickwede, M., Holtje, C., Chhatwal, G. S., Geffers, R., Medina, E. (2007). Transcriptome Analysis of Murine Macrophages in Response to Infection with Streptococcus pyogenes Reveals an Unusual Activation Program. Infect. Immun. 75: 4148-4157 [Abstract] [Full Text]  
  • Shao, X., Mednick, A., Alvarez, M., van Rooijen, N., Casadevall, A., Goldman, D. L. (2005). An Innate Immune System Cell Is a Major Determinant of Species-Related Susceptibility Differences to Fungal Pneumonia. J. Immunol. 175: 3244-3251 [Abstract] [Full Text]  
  • Okazaki, T., Ebihara, S., Takahashi, H., Asada, M., Kanda, A., Sasaki, H. (2005). Macrophage Colony-Stimulating Factor Induces Vascular Endothelial Growth Factor Production in Skeletal Muscle and Promotes Tumor Angiogenesis. J. Immunol. 174: 7531-7538 [Abstract] [Full Text]